About Mark Weisman

Chief Information Officer / Chief Medical Information Officer for TidalHealth, Inc.

Senior healthcare IT executive with over 20 years of experience developing solutions to drive growth as well as profitability in challenging and competitive markets. Recognized for promoting effective governance and positive change that improved operational efficiency, revenue, and cost savings. Decisive decision-maker that is entrepreneurial, solutions-focused, and results-oriented with a proven track record of success in large IT initiatives. Actively practicing physician with sophisticated understanding of hospital and ambulatory workflows, infrastructure development, and healthcare data management. Recognized as a national thought leader on healthcare IT topics, a frequent contributor to multiple media outlets, an AMIA informatics course instructor, and member of the KLAS Emerging Solutions Advisory Board.

Significant Epic experience since 2008 with deep knowledge of the clinical applications including Cerner to Epic conversion experience. Physician builder with projects that improve provider efficiency. Lead informatics and analytics around HCC, alerts, MyChart utilization, order set development, and provider optimization.

Major projects include:

• Instituted clinical informatics and provider led governance processes with dramatic improvements in end-user satisfaction.
• Directed multimillion dollar IT restructuring, eliminating legacy applications to reduce IT overhead with 10% reduction in IT staff and save $5M in operating budget.
• Remodeled the service desk and surpassed first call resolution rate and abandonment KPIs.
• Developed the “Home For Dinner” provider electronic medical record efficiency program. Achieved 98% provider satisfaction with the Epic optimization program.
• Transformed reporting into a high performing analytics team that delivers critical insights into business and clinical problems.
• Launched a new call center for the medical group and reduced call abandonment rate from 20% to under 5% within 2 months.